RP-606 rights revert to Medivir
Medivir announced that all rights relating to the development of RP-606 (MIV-606), an oral antiviral being developed for the treatment of herpes zoster (shingles) and post-herpetic neuralgia (PHN), the chronic pain which is associated with shingles, have been reverted to Medivir. The reversion is effected by way of a mutual termination of the license agreement with Reliant Pharmaceuticals, Inc., which is now focusing on the marketing and development of its portfolio of cardiovascular products.
"During the autumn Medivir has intensified its efforts to find an appropriate way forward for its shingles project MIV-606. With the termination of the Medivir-Reliant licensing agreement for MIV-606, all rights as well as all clinical and other data developed during the term of the agreement will be reverted to Medivir", says Medivir's CEO Lars Adlersson.
Most read news
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Long COVID makes thinking slower - Objective evidence for mental fatigue

Genetically engineered mice yield clues to 'knocking out' cancer
Algeta US Celebrates Official Opening of Operational Center in Cambridge, MA

Scientists characterise cancer genes using ground-breaking new method

Mapping chemicals in the skin - Reducing animal experiments with chemical imaging
List_of_subjects_in_Gray's_Anatomy:_VII._The_Veins
Occupational_lung_disease
List_of_subjects_in_Gray's_Anatomy:_XI._Splanchnology

Spider's web inspires removable implant that may control type 1 diabetes
Hormonal_therapy_(oncology)
